Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose.
Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose.
复制标题
DOI:
10.1016/j.drugpo.2020.103077
复制
发表时间:
2021-06
影响因子:
4.4
通讯作者:
Binswanger, Ingrid A.
中科院分区:
文献类型:
--
作者:
Mueller, Shane R.;Glanz, Jason M.;Nguyen, Anh P.;Stowell, Melanie;Koester, Stephen;Rinehart, Deborah J.;Binswanger, Ingrid A.
Despite policy efforts to prevent overdose, accidental overdoses among individuals prescribed opioids continue to occur. Guided by Rhodes’ Risk Environment Framework, we examined the unintended consequences of restrictive policies by identifying macro policy and micro-level contextual factors that patients prescribed opioids for pain identified as contributing to overdose events. Semi-structured interviews were conducted with 31 patients prescribed opioids who experienced an accidental opioid overdose between April 2017 and June 2019 in two health systems. We identified three interrelated factors that emerged within an evolving risk environment and may have increased patients’ vulnerability for an accidental opioid overdose: desperation from persistent pain and comorbidities; limited knowledge about opioid medication safety and effectiveness; and restrictive opioid prescribing policies that exacerbated stigma, fear and mistrust and prevented open patient-clinician communication. When experiencing persistent pain, patients took matters into their own hands by taking more medications or in different intervals than prescribed, mixing them with other substances, or using illicitly obtained opioids. For some patients, macro-level policies and guidelines designed to reduce opioid overdoses by restricting opioid supply may have paradoxically created a micro-level risk environment that contributed to overdose events in a subset of patients.
登录
查看更多内容
影响因子:
3.5
作者:
Hartung, Daniel M.;Kim, Hyunjee;Ahmed, Sharia M.;Middleton, Luke;Keast, Shellie;Deyo, Richard A.;Zhang, Kun;McConnell, K. John
通讯作者:
McConnell, K. John
影响因子:
5.7
作者:
Glanz, Jason M.;Narwaney, Komal J.;Binswanger, Ingrid A.
通讯作者:
Binswanger, Ingrid A.
DOI:
10.1016/j.drugpo.2017.06.008
发表时间:
2017-10
期刊:
The International journal on drug policy
影响因子:
--
作者:
Koester S;Mueller SR;Raville L;Langegger S;Binswanger IA
通讯作者:
Binswanger IA
影响因子:
3.8
作者:
Elo, Satu;Kyngaes, Helvi
通讯作者:
Kyngaes, Helvi
影响因子:
33.7
作者:
Dowell, Deborah;Haegerich, Tamara M.;Chou, Roger
通讯作者:
Chou, Roger